These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11909769)

  • 1. Preventing stroke.
    Schrader J; Lüders S
    BMJ; 2002 Mar; 324(7339):687-8. PubMed ID: 11909769
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing stroke with ramipril. Superiority of particular class of antihypertensive agent remains to be shown.
    Yudkin JS
    BMJ; 2002 Aug; 325(7361):439. PubMed ID: 12201280
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing stroke with ramipril. Benefits were considerably overstated.
    Wakeman AP; Wakeman JG
    BMJ; 2002 Aug; 325(7361):439. PubMed ID: 12201279
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing stroke with ramipril. Presentation of data is misleading.
    Parmar MS
    BMJ; 2002 Aug; 325(7361):439. PubMed ID: 12201281
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing stroke with ramipril. Results should have been presented in ways that help practising clinicians.
    Badrinath P
    BMJ; 2002 Aug; 325(7361):439. PubMed ID: 12193364
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood pressure drug helps prevent stroke.
    Health News; 2002 May; 8(5):6. PubMed ID: 12132410
    [No Abstract]   [Full Text] [Related]  

  • 7. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of ramipril in preventing stroke: double blind randomised trial.
    Bosch J; Yusuf S; Pogue J; Sleight P; Lonn E; Rangoonwala B; Davies R; Ostergren J; Probstfield J;
    BMJ; 2002 Mar; 324(7339):699-702. PubMed ID: 11909785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005].
    Traut V
    Dtsch Med Wochenschr; 2005 Nov; 130(47):2726; author reply 2727-8. PubMed ID: 16294292
    [No Abstract]   [Full Text] [Related]  

  • 11. Best bang for the buck?
    Weder AB
    Curr Hypertens Rep; 2003 Feb; 5(1):3-5. PubMed ID: 12530929
    [No Abstract]   [Full Text] [Related]  

  • 12. [Symposium "Emerging Approaches to Cardiovascular Diseases: Detailed results and implications of the HOPE Study". Atlanta, 10. November 1999].
    Bischoff A
    Internist (Berl); 2000 Jan; 41(1):A24-7. PubMed ID: 10712083
    [No Abstract]   [Full Text] [Related]  

  • 13. Stroke prevention: indapamide, a forgotten option?
    Parra Ruiz J; Muñoz Medina L; Miras Parra F; de la Higuera Torres-Puchol JM
    Stroke; 2003 Sep; 34(9):e156-7; author reply e156-7. PubMed ID: 12947159
    [No Abstract]   [Full Text] [Related]  

  • 14. Ramipril: the better angiotensin-converting enzyme inhibitor?
    Gupta R
    Indian Heart J; 2008; 60(3):188-91. PubMed ID: 19240304
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk reduction for stroke and coronary events.
    Peverill RE
    Lancet; 2002 Apr; 359(9313):1249; author reply 1250-1. PubMed ID: 11955568
    [No Abstract]   [Full Text] [Related]  

  • 16. Left ventricular hypertrophy: a "factor of risk": mass is reversible, but is the risk?
    Frohlich ED
    J Am Coll Cardiol; 2004 Jun; 43(12):2216-8. PubMed ID: 15193682
    [No Abstract]   [Full Text] [Related]  

  • 17. Who is fooling us?
    Mourad JJ; Safar ME; O'Rourke MF
    Lancet; 2002 Jul; 360(9326):89. PubMed ID: 12114069
    [No Abstract]   [Full Text] [Related]  

  • 18. Nondipping and cardiovascular risk after morning renin-angiotensin blockade.
    Portaluppi F; Smolensky M; Ayala DE; Hermida RC
    Hypertension; 2013 Feb; 61(2):e15. PubMed ID: 23248148
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ramipril and new therapeutic possibilities for ACE-inhibitors].
    Vespasiani Gentilucci U; Picardi A
    Clin Ter; 2000; 151(4):307-8. PubMed ID: 11107682
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of stroke: should high risk patients be treated with angiotensin II converting enzyme inhibitors without regard to their blood pressure levels? ].
    Kes P; Basić-Kes V
    Lijec Vjesn; 2003; 125(1-2):43-5. PubMed ID: 12812028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.